CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of kidney and urological disorders
3.4.1.2. Surge in technological advancements
3.4.1.3. Rise in demand for minimally invasive medical procedures
3.4.2. Restraints
3.4.2.1. High cost of urology devices
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Instruments Nephrology and Urology Devices Market by Type
4.2.4.1. Dialysis Devices Nephrology and Urology Devices Market by Type
4.2.4.2. Endoscopes Nephrology and Urology Devices Market by Type
4.3. Consumables and Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Consumables and Accessories Nephrology and Urology Devices Market by Type
CHAPTER 5: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY APPLICATIONS
5.1. Overview
5.1.1. Market size and forecast
5.2. Kidney Diseases
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Urological Cancer and BPH
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Dialysis Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Applications
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product
7.2.5.1.2. Market size and forecast, by Applications
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product
7.2.5.2.2. Market size and forecast, by Applications
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product
7.2.5.3.2. Market size and forecast, by Applications
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Applications
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product
7.3.5.1.2. Market size and forecast, by Applications
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product
7.3.5.2.2. Market size and forecast, by Applications
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product
7.3.5.3.2. Market size and forecast, by Applications
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product
7.3.5.4.2. Market size and forecast, by Applications
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product
7.3.5.5.2. Market size and forecast, by Applications
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product
7.3.5.6.2. Market size and forecast, by Applications
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Applications
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product
7.4.5.1.2. Market size and forecast, by Applications
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product
7.4.5.2.2. Market size and forecast, by Applications
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product
7.4.5.3.2. Market size and forecast, by Applications
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product
7.4.5.4.2. Market size and forecast, by Applications
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product
7.4.5.5.2. Market size and forecast, by Applications
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product
7.4.5.6.2. Market size and forecast, by Applications
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Applications
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product
7.5.5.1.2. Market size and forecast, by Applications
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product
7.5.5.2.2. Market size and forecast, by Applications
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product
7.5.5.3.2. Market size and forecast, by Applications
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product
7.5.5.4.2. Market size and forecast, by Applications
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic plc
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Boston Scientific Corporation
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. B. Braun SE
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Baxter International Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Coloplast
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Olympus Corporation
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Stryker Corporation.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Teleflex Incorporated
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Becton, Dickinson and Company
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Karl Storz GmbH & Co. KG
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
| ※参考情報 腎臓・泌尿器用機器は、腎臓および泌尿器系に関連する状態の診断、治療、モニタリングを支援するために使用される医療機器です。これらの機器は、腎臓や尿路の健康を維持するために重要な役割を果たしています。腎臓は体内の老廃物や余分な水分を排出する機能を持っており、泌尿器系はそれらの物質を体外に排出するための経路を提供します。このため、腎臓及び泌尿器系の疾患や異常を早期に見つけ、適切に対処することが重要です。 腎臓・泌尿器用機器には、多くの種類があります。その中でも、腎臓移植用機器、透析装置、尿路ストーム・カテーテル、尿検査機器、超音波検査装置などが代表的です。腎臓移植用機器は、腎臓移植手術時に必須の道具であり、移植前後の管理に使用されます。透析装置は、腎臓が正常に機能しない患者に対して血液中の老廃物を除去するための機器です。これにより、患者は腎不全と闘うことができます。 尿路ストーム・カテーテルは、尿を体外に排出するために使用されるチューブであり、尿道や膀胱の損傷や病状に対処する際に重要です。尿検査機器は、尿中の成分を分析するための装置であり、これによりさまざまな健康状態を把握することができます。超音波検査装置は、腎臓や尿管の状態を非侵襲的に評価するために使用され、結石や腫瘍の有無を確認する役割があります。 腎臓・泌尿器用機器の用途は多岐にわたります。透析装置を用いることで、腎機能が低下した患者は透析治療を受けることができ、生活の質を向上させることが可能です。また、尿検査によって、感染症や糖尿病、腎疾患などの早期発見が促進され、早期の治療が可能になります。超音波検査による画像診断は、腎臓や尿路の病変を特定するのに役立ちます。これらの機器は、医療従事者が患者を適切に診断し、効果的な治療を提供するために不可欠です。 関連技術として、遠隔医療や電子カルテの導入が挙げられます。これにより、腎臓・泌尿器領域においても医療情報の管理や患者とのコミュニケーションが円滑になり、治療方針の決定において迅速な情報共有が実現されます。また、人工知能（AI）を活用した画像診断技術も進展しており、超音波やCTスキャンの画像を解析することで、従来の診断方法よりもさらに高精度での病変の検出が期待されています。 腎臓・泌尿器用機器に関する技術革新は日々進行しており、新しい機器や治療法の開発が進められています。これにより、腎臓や泌尿器系の疾患に苦しむ患者にとって、より良い治療選択肢が提供される未来が期待されています。これらの機器は、専門的な知識を持つ医療従事者が適切に使用することで、その効果を最大限に引き出せるため、トレーニングや教育も重要です。 腎臓・泌尿器用機器は、患者の健康を守るための重要な道具として、今後も進化を続けるでしょう。医療従事者や研究者は、新しい技術を駆使しつつ、より多くの患者に対してより良い医療サービスを提供するために邁進することが求められています。腎臓・泌尿器用機器の発展は、医療界にとって重要な課題であり、未来の医療における鍵となるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
